CLINICAL_TRIALS
trial_result
· 2019-06-17
Clinical Trial Update: Botulinum Toxins Intralesional Injection for Scar Pain [Phase 4]
Summary
Phase 4 clinical trial update for intralesional botulinum toxin injections to treat scar pain in patients with scar keloid and hypertrophic scar.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kaohsiung Medical University | Conditions: Scar Keloid, Hypertrophic Scar | Phase 4 | Status: UNKNOWN